BIOGENERATION VENTURES
BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands. BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies. The BioGeneration Ventures team is specialized in the evaluation and management of early stage companies. Their involvement goes beyond the financial investment. They work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to opt... imize the commercial potential of their portfolio company's technologies. BioGeneration Ventures began operating in 2006 and the fund is backed by the Netherlands Genomics Initiative (NGI) and the Netherlands Organisation for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO Capital as lead private investors.
BIOGENERATION VENTURES
Social Links:
Industry:
Financial Services Life Science Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
+31 (0) 35 699 30 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Apps For Business
Similar Organizations
Salesforce Ventures
Salesforce Ventures invests in the next gen of enterprise tech to help companies connect with their customers in entirely new ways.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-10 | Scenic Biotech | BioGeneration Ventures investment in Series A - Scenic Biotech | 28 M EUR |
| 2022-02-23 | Complement Therapeutics | BioGeneration Ventures investment in Seed Round - Complement Therapeutics | 5 M EUR |
| 2022-01-20 | River BioMedics | BioGeneration Ventures investment in Seed Round - River BioMedics | 1.8 M EUR |
| 2021-12-17 | NorthSea Therapeutics | BioGeneration Ventures investment in Series C - NorthSea Therapeutics | 80 M USD |
| 2021-11-02 | Dunad Therapeutics | BioGeneration Ventures investment in Series A - Dunad Therapeutics | 24 M USD |
| 2021-01-01 | Complement Therapeutics | BioGeneration Ventures investment in Seed Round - Complement Therapeutics | N/A |
| 2020-11-19 | Catalym | BioGeneration Ventures investment in Series B - Catalym | 50 M EUR |
| 2020-07-08 | VarmX | BioGeneration Ventures investment in Series B - VarmX | 32 M EUR |
| 2020-07-02 | Citryll | BioGeneration Ventures investment in Series B - Citryll | 18.5 M EUR |
| 2020-02-06 | Azafaros | BioGeneration Ventures investment in Series A - Azafaros | 25 M EUR |
More informations about "BioGeneration Ventures"
About us - BioGeneration Ventures
Shaping new life-science ventures. The Forbion BGV Platform. BioGeneration Ventures (BGV) is the early-stage strategy of the Forbion-BGV platform of funds, which also includes Forbion …See details»
BioGeneration Ventures - Crunchbase
BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies. The BioGeneration Ventures team is specialized in the evaluation and management of early stage …See details»
BioGeneration Ventures - Investments, Portfolio & Company Exits
Jul 26, 2024 BioGeneration Ventures 's most notable exits include New Amsterdam Pharma, argenx, and AcertaPharma. Which industries has this organization had the most exits in? …See details»
BioGeneration Ventures closes BGV Fund V at €150 million
Jul 13, 2023 BioGeneration Ventures (BGV) is a venture capital company, with a focus on early-stage European biotech companies. With a strong track record of significant financial returns …See details»
BioGeneration Ventures | EU-Startups
BioGeneration Ventures (BGV) is a venture capital company focused on early-stage European biotech, medtech, and diagnostics companies. With a strong track record of significant …See details»
BioGeneration Ventures closes BGV Fund V at €150 million
Jul 13, 2023 BioGeneration Ventures (BGV) BGV’s largest fundraising to date, bringing total funds under management to over €400 million. BGV V was oversubscribed amid strong …See details»
BioGeneration Ventures - Funding, Financials, Valuation & Investors
BioGeneration Ventures has raised a total of €222M across 3 funds, their latest being BioGeneration Ventures Fund IV (BGV IV). This fund was announced on Jan 7, 2021 and …See details»
Contact - BioGeneration Ventures
Shaping new life-science ventures. About us; BGV Case Studies; Team; Portfolio; News; Careers; Contact; ... 1411 DC Naarden The Netherlands. Telephone +31 (0) 35 699 30 00: Email : …See details»
BioGeneration Ventures - Private Equity List
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of …See details»
BioGeneration Ventures closes 4th fund, with $170M in tow for …
Jan 7, 2021 BioGeneration Ventures has closed its BGV IV fund with help from some major pharma VC players as it becomes one of the largest biotech investors in early-stage ventures …See details»
Lonza, Forbion, and BioGeneration Ventures Extend Collaboration …
Basel, Switzerland, 18 January 2022 – Forbion, a leading venture capital firm building life sciences companies, BioGeneration Ventures (BGV), its joint venture partner and specialized …See details»
News - BioGeneration Ventures
Real Deals - BioGeneration Ventures closes its largest fund on €150m; July 14, 2023 Wall Street Journal Pro Venture Capital Newsletter; July 13, 2023 Endpoints News - BioGeneration …See details»
BGV co-leads €10 million seed investment in neuroscience
Nov 17, 2022 Amsterdam, The Netherlands, 17 November 2022 - BioGeneration Ventures (“BGV”), a leading early-stage VC in European biopharma today announces that it has co-led, …See details»
Geoff Beattie - Wikipedia
William Geoffrey Beattie (born 1960) is a Canadian business executive and former lawyer. He received his law degree from the University of Western Ontario in 1984 [3] and served as a …See details»
Tanai Therapeutics secures additional financing from Novo …
Ghent, Belgium, 19 September 2024 – Tanai Therapeutics (“the Company” or “Tanai”), a VIB spin-off company developing a new therapeutic class of obesity treatments, today announces …See details»
Staff & Board - SCAN of Northern Virginia
Meet our board. At SCAN, we are committed to our mission.In order to help us fulfill that mission, we have gathered a team of committed professionals who represent excellence and integrity in …See details»
Geoff Beattie - CEO @ Generation Capital - Crunchbase
Geoff is Chairman of Relay Ventures, an early stage venture fund exclusively focused on mobile computing. He received a law degree from the University of Western Ontario and served as a …See details»
The Best 10 Community Service/Non-Profit near Woodbridge, VA …
Best Community Service/Non-Profit near me in Woodbridge, VA 22191 - ECHO, Goodwill, Two Percent Project, Capital Area Community Food Bank, VFW Post 1503, Operation Paws for …See details»
Portfolio - BioGeneration Ventures
Shaping new life-science ventures. Dualyx aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity and improved patient …See details»